Holen Sie sich die Stockscreener-App
30.66
1.05%
-0.3238
Handel nachbörslich:
30.65
-0.0052
-0.02%
Schlusskurs vom Vortag:
$30.98
Offen:
$30.71
24-Stunden-Volumen:
7,313
Relative Volume:
0.84
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-0.63%
1M Leistung:
+3.65%
6M Leistung:
+20.98%
1J Leistung:
+9.84%
1-Tages-Spanne:
$30.19
$30.87
1-Wochen-Bereich:
$30.19
$31.23
52-Wochen-Spanne:
$20.10
$31.55
Tema Oncology Etf Stock (CANC) Company Profile
Firmenname
Tema Oncology Etf
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie CANC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CANC
Tema Oncology Etf
|
30.66 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
335.80 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
683.34 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
686.69 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
254.42 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
632.08 | 124.43B | 0 | 0 | 0 | 0.00 |
Tema Oncology Etf Aktie (CANC) Neueste Nachrichten
How (CANC) Movements Inform Risk Allocation Models - news.stocktradersdaily.com
Biotech ETFs Bounce Back in 2025: Here's Why - sharewise.com
Aug PostEarnings: Is Tema ETF Trust Tema International stock among top earnings playsInsider Selling & Reliable Volume Spike Trade Alerts - nchmf.gov.vn
5 Small-cap Biotech ETFs to Watch in 2025 - Investing News Network
ETFs with Bristol-Myers Squibb Company ( BMY ) Exposure - ETF Database
What hedge fund moves indicate for Tema ETF Trust Tema Monopolies stockLayoff News & Growth Focused Stock Reports - newser.com
Short Interest in Tema Oncology ETF (NASDAQ:CANC) Increases By 264.8% - Defense World
Tema Etfs LLC Grows Stock Holdings in CG Oncology, Inc. $CGON - MarketBeat
How to Take Advantage of moves in (CANC) - news.stocktradersdaily.com
Analysts Predict Tema Oncology ETF to Reach $40, with Stocks CELC, ACLX, and ZYME Showing Significant Upside Potential - AInvest
Summit Therapeutics Explodes 12%: Legal Probe Ignites Volatility Amid Regulatory Crosshairs - AInvest
Summit Therapeutics Soars 16.5% Amid Regulatory Crossroads and Whale Activity - AInvest
When (CANC) Moves Investors should Listen - news.stocktradersdaily.com
5 Small-cap Biotech ETFs to Watch - Nasdaq
(CANC) Investment Report - news.stocktradersdaily.com
(CANC) Technical Data - news.stocktradersdaily.com
Bristol-Myers Squibb At ASCO 2025: A Resilient Play Amid Market Turbulence (NYSE:BMY) - Seeking Alpha
ITM and Radiopharm Sign Supply Agreement for n.c.a. Lutetium-177 - Investing News Network
Learn to Evaluate (CANC) using the Charts - news.stocktradersdaily.com
Biotech Outperformance: Can’t Take What’s Already Earned - Seeking Alpha
AAPG Stock Price and Chart — NASDAQ:AAPG - TradingView
7 Best-Performing Biotech ETFs for March 2025 - NerdWallet
Disruptive Theme of the Week: Breakthroughs in Medicine - ETF Trends
Tema ETF Trust Tema Oncology ETF (NASDAQ: CANC)Related Research - intelligentinvestor.com.au
5 Small-cap Biotech ETFs to Watch (Updated 2024) - Nasdaq
Tema American Reshoring ETF: Benefiting From The Return Of U.S. Manufacturing - Seeking Alpha
Tema Oncology ETF (CANC) Holdings - Yahoo! Finance Canada
Tema Oncology ETF (CANC) stock price, news, quote and history - Yahoo! Finance UK
Tema Oncology ETF (CANC) Stock Trends and Sentiment 2025 - MarketBeat
Tema ETFs CIO on Investment Opportunities in Biotech - CMC Markets
Pursuing A Better Way To Invest In Life Sciences | Opto Partners - CMC Markets
How Big Pharma Is Taking A Page Out Of Novartis' Playbook - Investor's Business Daily
10 Best Performing Biotech ETFs in 2024 - Yahoo Finance
9 Best Biotech ETFs for 2024 - AOL.com
The 5 Best Biotech ETFs of 2024 - ETF.com
11 Best Biotech ETFs To Buy - Yahoo Finance
CANC ETF Analysis: Dividends, Returns NASDAQ:CANC - TradingView
Roundhill Daily 2X Long Magnificent Seven ETF Holdings List (NASDAQ:MAGX) - MarketBeat
ERShares Entrepreneurs ETF (ENTR) Short Interest Ratio and Volume 2025 - MarketBeat
Tema Launches Third Medical-Themed ETF - FA Mag
Tema Oncology ETF (CANC) Dividend Yield 2025, Date & History - MarketBeat
New ETF Focuses On Obesity, Cardiovascular Disease Treatments - FA Mag
Tema ETFs hops on weight-loss drug frenzy with its new cardiovascular fund - Reuters
NYSE Active ETF Update | October 12, 2023 - NYSE
12 Best Healthcare ETFs To Buy - Yahoo Finance
Investing in Oncology: A Biotech Revolution in Research, Diagnosis, and Treatment of Cancer - Nasdaq
Inside Tema ETFs' New Oncology ETF (CANC) - Yahoo Finance
Royalties and cancer treatments: Thematic ETFs take new directions - InvestmentNews
Tema unveils thematic ETFs on oncology and royalties - ETF Strategy
CANC Stock Fund Price and Chart — NASDAQ:CANC - TradingView
Tema Launches Two Innovative, Active ETF Thematic Strategies: Oncology & Global Royalties - Business Wire
Finanzdaten der Tema Oncology Etf-Aktie (CANC)
Es liegen keine Finanzdaten für Tema Oncology Etf (CANC) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.47%
0.60%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):